Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celecoxib add-on to vortioxetine guided by CRP in major depressive disorder
ACTRN12617000527369Phase 4Terminated
- Sponsor
- Professor Bernhard Baune
- Start
- Dec 2017
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of celecoxib and vortioxetine in major depressive disorder (MDD) (4 arms), sponsored by Professor Bernhard Baune. Primary endpoint: MADRS response. Started Dec 2017; status: terminated.
02
Drugs
celecoxibvortioxetine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on ACTRN12617000527369.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12617000527369.